UK's Most Competitive Wegovy & Mounjaro Pricing
Understanding the Core Difference Between Wegovy and Mounjaro UK Pricing
The difference between Wegovy and Mounjaro UK pricing reflects their distinct mechanisms and market positioning. Wegovy (semaglutide) operates as a GLP-1 receptor agonist, while Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist. At EverydayMeds, we've structured our pricing to offer the lowest costs for both treatments, ensuring patients can access these prescription-only medicines without compromising on quality or service. Our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose.
Both treatments require careful dose escalation and ongoing clinical monitoring, which is why our pricing includes comprehensive prescriber reviews and clinical assessments. The difference between Wegovy and Mounjaro UK availability has meant that many patients compare costs when discussing options with their healthcare providers, and our transparent pricing structure helps inform these important decisions.
Comprehensive Wegovy and Mounjaro UK Price Comparison
When evaluating the difference between Wegovy and Mounjaro UK costs, it's essential to consider the complete treatment journey. Our Wegovy single pen prices include clinical assessment, prescriber review, and cold-chain delivery: 0.25mg at £79.99, 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and 2.4mg maintenance at £209.99. We also offer convenient bundle options like the Intro Duo (0.25mg & 0.5mg) for £169.99 and Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access these competitive rates.
The difference between Wegovy and Mounjaro UK pricing structures reflects their different dosing schedules and treatment protocols. While both require prescription-only access, our bundled pricing options provide convenience for patients committed to their weight management journey. Our Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99, providing treatment continuity without repeated ordering processes.
Clinical Evidence Supporting Wegovy and Mounjaro UK Treatment Decisions
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes. The STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst the STEP 5 study showed sustained clinically studied weight loss at two years (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events with semaglutide treatment.
Understanding the difference between Wegovy and Mounjaro UK clinical profiles helps inform treatment selection. Both treatments have shown efficacy in clinical trials, though direct head-to-head comparisons are limited due to different trial designs and patient populations. Your prescriber can help determine which treatment aligns with your clinical profile and treatment goals.
How Wegovy Works: GLP-1 Mechanism for UK Patients
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines. This mechanism may help reduce appetite by acting on brain centres that control hunger and satiety, potentially leading to smaller portion sizes and reduced food cravings. The medication works by slowing gastric emptying, which may promote feelings of fullness after meals and support adherence to a reduced-calorie diet. Unlike Mounjaro's dual mechanism targeting both GIP and GLP-1 receptors, Wegovy focuses specifically on GLP-1 pathways. This targeted approach has been extensively studied in the STEP clinical trial programme, demonstrating its potential effectiveness when combined with lifestyle modifications. The once-weekly injection schedule using the FlexTouch pen system provides convenience for long-term weight management commitment.
EverydayMeds UK Ordering Process: Wegovy and Mounjaro Access
Our streamlined process eliminates the complexity often associated with accessing prescription-only weight management treatments. The journey begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and treatment goals. Following submission, our qualified prescribers review your assessment within standard 3 working days, with express 24-hour reviews available for urgent requirements. Once approved, your medication ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for maintaining medication efficacy. Our GPhC-registered pharmacy (#9012878) ensures all medications are genuine Novo Nordisk products, properly stored and handled throughout the supply chain. Both new customers using code FIRST40 and returning customers with DOSE25 receive the same professional service and clinical oversight regardless of their chosen treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro UK
The difference between Wegovy and Mounjaro UK storage requirements presents practical advantages for certain lifestyles. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or those with variable schedules. Both treatments require refrigerated storage at 2-8°C before first use and utilise pre-filled injection pens for convenience. The mandatory dose escalation schedule for Wegovy progresses over 16 weeks to reach the 2.4mg maintenance dose, allowing your body to gradually adjust to the medication. Our cold-chain delivery ensures your medication arrives at the correct temperature, maintaining its effectiveness throughout the treatment journey.
Why EverydayMeds Offers the Best Wegovy and Mounjaro UK Value
The difference between Wegovy and Mounjaro UK pricing at EverydayMeds reflects our commitment to accessible, transparent healthcare. Unlike many providers who add consultation fees, delivery charges, or membership costs, our prices include everything needed for successful treatment initiation. Our clinical team provides ongoing support throughout your weight management journey, ensuring you understand proper injection technique, dose escalation schedules, and potential side effect management.
Both Wegovy and Mounjaro are available through our platform, allowing you and your prescriber to choose the most appropriate treatment based on clinical factors rather than availability constraints. Our competitive pricing, combined with professional clinical oversight and reliable supply chains, positions EverydayMeds as the preferred choice for UK patients seeking prescription weight management solutions.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your clinical profile and lifestyle requirements. Our transparent pricing eliminates the guesswork from treatment costs, while our professional clinical team ensures you receive appropriate ongoing support throughout your weight management journey. New customers can begin their clinical assessment today using discount code FIRST40, while returning customers continue their treatment with code DOSE25 for continued competitive pricing. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your 3-minute clinical assessment and take the first step towards effective weight management. Remember that weight management is a long-term commitment requiring dedication to dietary changes and increased physical activity alongside your chosen prescription treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
